Finance

Lists
317450:KRX
Myung In Pharm Co Ltd
â‚©44,550.00
-0.22%
(-100.00) 1D
Sep 7, 3:30:18 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 317450...
Open
â‚©44,800
High
â‚©45,150
Low
â‚©44,500
Mkt. cap
650.43B
Avg. vol.
18.94K
Volume
5.00K
Dividend
2.24%
Quarterly dividend
â‚©250
Ex-dividend date
Aug 28, 2026
P/E ratio
4.71
52-wk high
â‚©134,500
52-wk low
â‚©39,100
EPS
â‚©9,453
Shares outstanding
14.60M
Open
â‚©44,800
High
â‚©45,150
Low
â‚©44,500
Mkt. cap
650.43B
Avg. vol.
18.94K
Volume
5.00K
Dividend
2.24%
Quarterly dividend
â‚©250
Ex-dividend date
Aug 28, 2026
P/E ratio
4.71
52-wk high
â‚©134,500
52-wk low
â‚©39,100
EPS
â‚©9,453
Shares outstanding
14.60M
About Myung In Pharm Co Ltd
CEOLee Hang Myung | Kim Jae-hyuk | Ko Dong-kyu
Employees-
FoundedApr 1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
72.70B
72.09B
72.14B
76.11B
Cost of goods sold
28.31B
28.44B
27.56B
27.73B
Cost of revenue
28.31B
28.44B
27.56B
27.73B
Research and development expenses
1.37B
1.42B
1.10B
2.20B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.79B
17.14B
17.47B
17.72B
Operating expense
22.48B
19.98B
19.47B
20.77B
Total operating expenses
50.78B
48.42B
47.03B
48.49B
Operating income
21.91B
23.67B
25.11B
27.61B
Other non operating income
206.58M
15.97M
446.90M
93.97M
EBT including unusual items
24.11B
26.79B
30.04B
31.82B
EBT excluding unusual items
24.11B
26.77B
30.04B
31.82B
Income tax expense
5.56B
3.53B
7.31B
7.50B
Effective tax rate
23.05%
13.20%
24.32%
23.57%
Other operating expenses
614.50M
533.43M
318.66M
288.62M
Net income
18.55B
23.25B
22.73B
24.32B
Net profit margin
25.51%
32.25%
31.51%
31.96%
Earnings per share
-
-
-
-
Interest and investment income
1.72B
3.26B
3.55B
3.54B
Interest expense
-57.80M
-55.11M
-54.73M
-56.49M
Net interest expenses
1.67B
3.20B
3.50B
3.48B
Depreciation and amortization charges
636.54M
648.53M
612.05M
617.68M
EBITDA
24.47B
26.18B
27.62B
30.19B
Gain or loss from assets sale
904.00K
-21.89M
-
-
AI content may include mistakes. Learn more
Google apps